Trademark Overview
On Friday, October 31, 2025, a trademark application was filed for THERALLO with the United States Patent and Trademark Office. The USPTO has given the THERALLO trademark a serial number of 99472514. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, March 24, 2026. This trademark is owned by THERALLO. The THERALLO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; Anti-inflammatories; Pharmaceutical preparations for activating cell function for medical purposes; Biological preparations for the treatment of cancer; Biological preparations for use in cell cultures for medical purposes; Biochemical reagents for medical or veterinary purposes; Biological tissue cultures for medical purposes; Stem cells for medical purposes; Cell culture media for medical purposes
Research and development in the field of allogeneic and autologous molecular and cell therapies; Scientific and technological services, namely, research and design in the field of allogeneic and autologous molecular and cell therapies; Medical research services; Pharmaceutical research services; Research and development in the field of stem cells, cell and gene therapy and biotechnology; Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing scientific research information in the field of stem cells, cell and gene therapy and biotechnology; Scientific study and research in the field(s) of molecular and allogeneic or autologous cell therapy; Providing medical and scientific research information
